Abstract
Objectives
The aim of this study is to better understand patients’ perspectives and preferences about treatment with continuous positive airway pressure (CPAP) and oral appliance (OA) devices for obstructive sleep apnea.
Methods
The current study used qualitative analysis of four focus group sessions with current CPAP and OA users. Twenty-two participants with OSA who currently use either CPAP or OA participated in the sessions at the University of British Columbia.
Results
Five topics from the focus group sessions were descriptively analyzed using NVivo software: goals and expectations of treatment, benefits of treatment for bed partners, side effects and inconveniences of CPAP, side effects and inconveniences of OA, and factors impacting treatment choice. In order of most to least frequently mentioned, patients expressed six expectations of treatment: improved health, apnea elimination, improved sleep, reduced fatigue, reduced snoring, and bed-partner benefits. The most to least mentioned factors impacting treatment choice were device effectiveness, transportability, embarrassment, and cost.
Conclusions
This qualitative study showed that many factors impact patients’ experience with their treatment device and that their treatment needs are not only physical but also relate to their lifestyle. This preliminary study provides treatment characteristics and attributes necessary to develop a quantitative questionnaire study, to assist in the selection of therapy, weighing the relative importance of patient and OSA treatment characteristics on treatment preference and adherence. Matching therapy to patient preferences may help identify the most appropriate treatment, and this may achieve greater likelihood of adherence.
References
Goncalves MA, Paiva T, Ramos E, Guilleminault C (2004) Obstructive sleep apnea syndrome, sleepiness, and quality of life. Chest 125(6):2091–2096
Young T, Skatrud J, Peppard PE (2004) Risk factors for obstructive sleep apnea in adults. JAMA 291(16):2013–2016
George CFP (2007) Sleep apnea, alertness, and motor vehicle crashes. Am J Respir Crit Care Med 176(10):954–956
Mulgrew AT, Nasvadi G, Butt A, Cheema R, Fox N, Fleetham JA, Ryan CF, Cooper P, Ayas NT (2008) Risk and severity of motor vehicle crashes in patients with obstructive sleep apnoea/hypopnoea. Thorax 63(6):536–541
Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053
Shapiro GK, Shapiro CM (2010) Factors that influence CPAP adherence: an overview. Sleep Breath 14:323–335
Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W (2006) Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 29(2):244–262
McCombs J, Nichol M, Newman C, Sclar D (1994) The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care 32(3):214–226
Bansback NJ, Anis AH, Marra CA (2008) Patient reported outcomes for rheumatoid arthritis: where are we and where are we going? J Rheumatol 35(8):1482–1483
Sabaté E, WHO Adherence to Long Term Therapies Project, Global Adherence Interdisciplinary Network, World Health Organization, Dept. of Management of Noncommunicable Diseases (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva
Morgan DL (1988) Focus groups as qualitative research. Sage, Newbury Park
Macnaghten P, Myers G (2004) Focus groups. In: Seale C, Gobo G, Gubrium JF, Silverman D (eds) Qualitative research practice. Sage, London, pp 312–326
Roux L, Ubach C, Donaldson C, Ryan M (2004) Valuing the benefits of weight loss programs: an application of the discrete choice experiment. Obes Res 12(8):1342–1351
Ryan M (2004) Discrete choice experiments in health care. BMJ 328(7436):360–361
Sandelowski M (2000) Whatever happened to qualitative description? Res Nurs Heal 23(4):334–340
US Department of Labor (2010) Standard occupational classification. Bureau of Labor Statistics, available at http://www.bls.gov/soc/classification.htm. Accessed July 6, 2011
Brostrom A, Arestedt K, Nilsen P, Stromberg A, Ulander M, Svanborg E (2010) The side-effects to CPAP treatment inventory: the development and initial validation of a new tool for the measurement of side-effects to CPAP treatment. J Sleep Res 19(4):603–611
Almeida FR, Lowe AA (2009) Principles of oral appliance therapy for the management of snoring and sleep disordered breathing. Oral Maxillofac Surg Clin North Am 21(4):413–420
Brostrom A, Stromberg A, Ulander M, Fridlund B, Martensson J, Svanborg E (2009) Perceived informational needs, side-effects and their consequences on adherence—a comparison between CPAP treated patients with OSAS and healthcare personnel. Patient Educ Couns 74(2):228–235
Weaver TE (2006) Adherence to positive airway pressure therapy. Curr Opin Pulm Med 12(6):409–413
Platt A, Field S, Asch D, Chen Z, Patel N, Gupta R, Roche D, Gurubhagavatula I, Christie J, Kuna S (2009) Neighborhood of residence is associated with daily adherence to CPAP therapy. Sleep 32:799–806
Simon-Tuval T, Reuveni H, Greenberg-Dotan S, Oksenberg A, Tal A, Tarasiuk A (2009) Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment. Sleep 32:545–552
Taylor S (2006) Health psychology. McGraw Hill, Toronto
Brostrom A, Nilsen P, Johansson P, Ulander M, Stromberg A, Svanborg E, Fridlund B (2009) Putative facilitators and barriers for adherence to CPAP treatment in patients with obstructive sleep apnea syndrome: a qualitative content analysis. Sleep Medicine 11(2):126–130
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 17 kb)
About this article
Cite this article
Almeida, F.R., Henrich, N., Marra, C. et al. Patient preferences and experiences of CPAP and oral appliances for the treatment of obstructive sleep apnea: a qualitative analysis. Sleep Breath 17, 659–666 (2013). https://doi.org/10.1007/s11325-012-0739-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-012-0739-6